Literature DB >> 22730332

Evaluation of the effectiveness of risk minimization measures.

Luis Prieto, Almath Spooner, Ana Hidalgo-Simon, Annalisa Rubino, Xavier Kurz, Peter Arlett.   

Abstract

Mesh：

Year:  2012        PMID： 22730332     DOI： 10.1002/pds.3305

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN： 1053-8569            Impact factor:   2.890


× No keyword cloud information.
  23 in total

Review 1.  Post-approval evaluation of effectiveness of risk minimisation: methods, challenges and interpretation.

Authors:  Anjan Kumar Banerjee; Inge M Zomerdijk; Stella Wooder; Simon Ingate; Stephen J Mayall
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

2.  The Additional Value of an E-Mail to Inform Healthcare Professionals of a Drug Safety Issue: A Randomized Controlled Trial in the Netherlands.

Authors:  Sigrid Piening; Pieter A de Graeff; Sabine M J M Straus; Flora M Haaijer-Ruskamp; Peter G M Mol
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

3.  Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy.

Authors:  Janet Sultana; Andrea Fontana; Francesco Giorgianni; Silvia Tillati; Claudio Cricelli; Alessandro Pasqua; Elisabetta Patorno; Clive Ballard; Miriam Sturkenboom; Gianluca Trifirò
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

Review 4.  Study design, process and outcome indicators of post-authorization studies aimed at evaluating the effectiveness of risk minimization measures in the EU PAS Register.

Authors:  Andreea Farcas; Madalina Huruba; Cristina Mogosan
Journal:  Br J Clin Pharmacol       Date:  2018-12-27       Impact factor: 4.335

5.  Quality of Reporting on the Evaluation of Risk Minimization Programs: A Systematic Review.

Authors:  Andrea M Russell; Elaine H Morrato; Rebecca M Lovett; Meredith Y Smith
Journal:  Drug Saf       Date:  2020-05       Impact factor: 5.606

6.  Using Clinical Databases to Verify the Impact of Regulatory Agency Alerts in Japan: Hepatitis B Testing Behavior After an Alert Regarding Risk of Viral Reactivation.

Authors:  Yukio Udagawa; Shinya Ohno; Shintaro Nakagawa; Kazutaka Sugimoto; Joji Mochizuki
Journal:  Drugs Real World Outcomes       Date:  2015-09

7.  European Survey of Prescriber Understanding of Risks Associated with Retigabine.

Authors:  Lianna Ishihara; Anne Lewis; Sathish Kolli; Neil Brickel
Journal:  Drugs Real World Outcomes       Date:  2015-11-16

8.  Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.

Authors:  Meredith Y Smith; Elaine Morrato
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

9.  The Effectiveness of an Educational Brochure as a Risk Minimization Activity to Communicate Important Rare Adverse Events to Health-Care Professionals.

Authors:  Nicolette Bester; Michelle Di Vito-Smith; Theresa McGarry; Michael Riffkin; Stefan Kaehler; Richard Pilot; Robert Bwire
Journal:  Adv Ther       Date:  2016-01-23       Impact factor: 3.845

10.  Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.

Authors:  Kimberly H Davis; Alex Asiimwe; Laurie J Zografos; David J McSorley; Elizabeth B Andrews
Journal:  Pharmaceut Med       Date:  2017-08-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.